ENTR-601-44
ENTR-601-44-201
Phase 2 small_molecule active
Quick answer
ENTR-601-44 for Duchenne Muscular Dystrophy (DMD) is a Phase 2 program (small_molecule) at Entrada Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Entrada Therapeutics
- Indication
- Duchenne Muscular Dystrophy (DMD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active